HORMONE USE, REPRODUCTIVE HISTORY AND RISK OF LUNG CANCER: THE WOMEN'S HEALTH INITIATIVE STUDIES

Por Schwartz, Ann G., Ray, Roberta M., Cote, Michele L., Abrams, Judith, Sokol, Robert J., Hendrix, Susan L., Chen, Chu, Chlebowski, Rowan T., Hubbell, F. Allan, Kooperberg, Charles, Manson, JoAnn E., Jo O'Sullivan, Mary, Rohan, Thomas, Stefanick, Marcia L., Wactawski-Wende, Jean, Wakelee, Heather, Simon, Michael S.
Publicado no J Thorac Oncol (2015)

Lung cancer risk prediction using common SNPs located in GWAS-identified susceptibility regions

Por Weissfeld, Joel L., Lin, Yan, Lin, Hui-Min, Kurland, Brenda F., Wilson, David O., Fuhrman, Carl R., Pennathur, Arjun, Romkes, Marjorie, Nukui, Tomoko, Yuan, Jian-Min, Siegfried, Jill M., Diergaarde, Brenda
Publicado no J Thorac Oncol (2015)

Impact of a Contralateral Tumor Nodule on Survival in Non-Small Cell Lung Cancer

Por Morris, Zachary S., Cannon, Donald M., Morris, Brett A., Bentzen, Søren M., Kozak, Kevin R.
Publicado no J Thorac Oncol (2015)

Obatoclax Mesylate, a Pan–Bcl-2 Inhibitor, in Combination with Docetaxel in a Phase 1/2 Trial in Relapsed Non–Small-Cell Lung Cancer

Por Chiappori, Alberto, Williams, Charles, Northfelt, Donald W., Adams, John W., Malik, Shakun, Edelman, Martin J., Rosen, Peter, Van Echo, David A., Berger, Mark S., Haura, Eric B.
Publicado no J Thorac Oncol (2014)

Treatment Outcomes in Stage I Lung Cancer: A Comparison of Surgery and Stereotactic Body Radiation Therapy (SBRT)

Por Puri, Varun, Crabtree, Traves D., Bell, Jennifer M., Broderick, Stephen R, Morgensztern, Daniel, Colditz, Graham A., Kreisel, Daniel, Krupnick, A. Sasha, Patterson, G. Alexander, Meyers, Bryan F., Patel, Aalok, Robinson, Clifford G.
Publicado no J Thorac Oncol (2015)

HER2 amplification and HER2 mutation are distinct molecular targets in lung cancers

Por Li, Bob T., Ross, Dara S., Aisner, Dara L., Chaft, Jamie E., Hsu, Meier, Kako, Severine L., Kris, Mark G., Varella-Garcia, Marileila, Arcila, Maria E.
Publicado no J Thorac Oncol (2015)

Prevalence, prognostic implications and survival modulators of incompletely resected non-small-cell lung cancer in the US National Cancer Data Base

Por Osarogiagbon, Raymond U., Lin, Chun Chieh, Smeltzer, Matthew P., Jemal, Ahmedin
Publicado no J Thorac Oncol (2016)

A Phase I Study of Light Dose for Photodynamic Therapy (PDT) Using 2-[1-hexyloxyethyl]-2 devinyl Pyropheophorbide-a (HPPH) for Treatment of Non-small Cell Carcinoma in situ or Non-...

Por Dhillon, Samjot Singh, Demmy, Todd L., Yendamuri, Sai, Loewen, Gregory, Nwogu, Chukwumere, Cooper, Michele, Henderson, Barbara W.
Publicado no J Thorac Oncol (2015)

Nodal Upstaging is More Common with Thoracotomy versus VATS During Lobectomy for Early Stage Lung Cancer: An Analysis from the National Cancer Data Base

Por Medbery, Rachel L., Gillespie, Theresa W., Liu, Yuan, Nickleach, Dana C, Lipscomb, Joseph, Sancheti, Manu S., Pickens, Allan, Force, Seth D., Fernandez, Felix G.
Publicado no J Thorac Oncol (2016)

Early Detection of Lung Cancer with Meso Tetra (4-Carboxyphenyl) Porphyrin-Labeled Sputum

Por Patriquin, Lara, Merrick, Daniel T., Hill, David, Holcomb, Richard G., Lemieux, Madeleine E., Bennett, Gordon, Karia, Bijal, Rebel, Vivienne I., Bauer, Thomas
Publicado no J Thorac Oncol (2015)

Comprehensive Pathological Analyses in Lung Squamous Cell Carcinoma: Single Cell Invasion, Nuclear Diameter and Tumor Budding Are Independent Prognostic Factors for Worse Outcomes

Por Kadota, Kyuichi, Nitadori, Jun-ichi, Woo, Kaitlin M., Sima, Camelia S., Finley, David J., Rusch, Valerie W., Adusumilli, Prasad S., Travis, William D.
Publicado no J Thorac Oncol (2014)

Adaptive neoadjuvant chemotherapy guided by (18)F-FDG-PET in resectable non-small-cell lung cancers: the NEOSCAN trial

Por Chaft, Jamie E., Dunphy, Mark, Naidoo, Jarushka, Travis, William D., Hellmann, Matthew, Woo, Kaitlin, Downey, Robert, Rusch, Valerie, Ginsberg, Michelle S., Azzoli, Christopher G., Kris, Mark G.
Publicado no J Thorac Oncol (2015)

Validations of SCT Methylation as a Hallmark Biomarker for Lung Cancers

Por Zhang, Yu-An, Ma, Xiaotu, Sathe, Adwait, Fujimoto, Junya, Wistuba, Ignacio, Lam, Stephen, Yatabe, Yasushi, Wang, Yi-Wei, Stastny, Victor, Gao, Boning, Larsen, Jill E, Girard, Luc, Liu, Xiaoyun, Song, Kai, Behrens, Carmen, Kalhor, Neda, Xie, Yang, Zhang, Michael Q, Minna, John D, Gazdar, Adi F
Publicado no J Thorac Oncol (2015)

A sensitive NanoString-based assay to score STK11 (LKB1) pathway disruption in lung adenocarcinoma

Por Chen, Lu, Engel, Brienne E., Welsh, Eric A., Yoder, Sean J., Brantley, Stephen G., Chen, Dung-Tsa, Beg, Amer A., Cao, Chunxia, Kaye, Frederic J., Haura, Eric B., Schabath, Matthew B., Cress, W. Douglas
Publicado no J Thorac Oncol (2016)

Phase II Study of a Non-platinum-containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab (PPB) as Initial Therapy for Patients with Advanced Lung Adenocarcinomas

Por Pietanza, Catherine M., Hellmann, Matthew D., Fiore, John J., Smith-Marrone, Stephanie, Basch, Ethan M., Schwartz, Lawrence H., Ginsberg, Michelle S., Shouery, Marwan, Newman, Samantha K., Shaw, Mary, Rogak, Lauren J., Lash, Alex, Hilden, Patrick, Kris, Mark G.
Publicado no J Thorac Oncol (2016)

An activating KIT mutation induces crizotinib resistance in ROS1 positive lung cancer

Por Dziadziuszko, Rafal, Le BA, Anh T., Wrona, Anna, Jassem, Jacek, Camidge, D. Ross, Varella-Garcia, Marileila, Aisner, Dara L., Doebele, Robert C.
Publicado no J Thorac Oncol (2016)

Five-year survival in EGFR-mutant metastatic lung adenocarcinoma treated with EGFR-TKIs

Por Lin, Jessica J., Cardarella, Stephanie, Lydon, Christine A., Dahlberg, Suzanne E., Jackman, David M., Jänne, Pasi A., Johnson, Bruce E.
Publicado no J Thorac Oncol (2015)

Trends of High-risk Subpopulations for Lung Cancer

Por Yang, Ping, Wang, Yi, Wampfler, Jason A, Xie, Dong, Stoddard, Shawn M, She, Jun, Midthun, David E
Publicado no J Thorac Oncol (2016)

Brief Report: S768I mutation in EGFR in patients with lung cancer

Por Leventakos, Konstantinos, Kipp, Benjamin R., Rumilla, Kandelaria M., Winters, Jennifer L., Yi, Eunhee S., Mansfield, Aaron S.
Publicado no J Thorac Oncol (2016)

EGFR:GRB2 protein co-localization is a prognostic factor unrelated to overall EGFR expression or EGFR Mutation in Lung Adenocarcinoma

Por Toki, Maria I., Carvajal-Hausdorf, Daniel E., Altan, Mehmet, McLaughlin, Joseph, Henick, Brian, Schalper, Kurt, Syrigos, Konstantinos N., Rimm, David L.
Publicado no J Thorac Oncol (2016)